Glenmark, Laurus Lab: Will Trump's 200% tariff threat derail pharma stocks?

Donald Trump threatens of a potential 200% tariff on pharma imports; can this derail the rally in pharma shares, which have gained up to 50% in 3 months. Here's what the technical charts suggest.

The US president Donald Trump has threatened potential 200 per cent tariffs on pharma imports. As per reports, Trump said he plans to impose tariffs on imported pharmaceuticals, with medicine tariffs potentially reaching 200 per cent. However, he said drug-makers would be given about a year "to get their act together".  In the Indian stock markets, pharma-related shares have rallied smartly over the last three months despite the US tariff threat. The Nifty Pharma index surged nearly 16 per cent from its low of 19,121 hit on April 7, 2025. In the same period, the NSE Nifty 50 index